Part Number : NDC52544-0371-10 | Manufacturer : Watson Labs Inc | ||
NSN : 6505-01-048-3719 (6505010483719) | |||
Item Name : Loxapine Capsules Usp | CAGE Code : 0BN85 | ||
NIIN : 01-048-3719 (010483719) | |||
INC Code : 49896 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC52544037110 |
Thank you for taking an interest in part number NDC52544-0371-10, that of which is listed with the description Loxapine Capsules Usp; Manufactured by Watson Labs Inc and listed alongside the NSN 6505010483719, part number NDC52544-0371-10 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC52544-0371-10 | Manufacturer : Watson Labs Inc | ||
NSN Number : 6505-01-048-3719 (6505010483719) | |||
Item Name : Loxapine Capsules Usp | CAGE Code : 0BN85 | ||
NIIN : 010483719 |
Thank you for taking an interest in part number NDC52544-0371-10, that of which is listed with the description Loxapine Capsules Usp; Manufactured by Watson Labs Inc and listed alongside the NSN 6505010483719, part number NDC52544-0371-10 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-048-3719 Item PartTypeName: LOXAPINE CAPSULES | 6505 | 010483719 | Q | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC17236-0695-10 | 2 | 9 | 5 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LOXAPINE CAPSULES USP 25MG 100S BT |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote